Patents by Inventor In Hye Kang
In Hye Kang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 8569364Abstract: Methods of inhibiting cytochrome P450 2D6 enzymes are provided that can be used for improving the treatment of diseases by preventing degradation of drugs or other molecules by cytochrome P450 2D6. Pharmaceutical compositions are provided that can act as boosters to improve the pharmacokinetics, enhance the bioavailability, and enhance the therapeutic effect of drugs that undergo in vivo degradation by cytochrome P450 2D6 enzymes.Type: GrantFiled: November 26, 2008Date of Patent: October 29, 2013Assignee: Sequoia Pharmaceuticals, Inc.Inventors: Michael Eissenstat, Dehui Duan, Ji-Hye Kang
-
Patent number: 8329442Abstract: Disclosed herein are is a novel bacteriophage which has specific bactericidal activity against one or more Salmonella bacteria selected from the group consisting of Salmonella Enteritidis, Salmonella Typhimurium, Salmonella Gallinarum, and Salmonella Pullorum without affecting beneficial bacteria. Disclosed are also compositions, animal feeds or drinking water, cleaners and sanitizers for preventing and treating the infectious diseases caused by Salmonella Enteritidis, Salmonella Typhimurium, Salmonella Gallinarum or Salmonella Pullorum including salmonellosis, Salmonella food poisoning, Fowl Typhoid, and Pullorum disease or for controlling the salmonella bacteria.Type: GrantFiled: September 3, 2010Date of Patent: December 11, 2012Assignee: CJ Cheiljedang CorporationInventors: Soo An Shin, Min Tae Park, Hyang Choi, Young Wook Cho, In Hye Kang, Su Jin Choi
-
Patent number: 8293515Abstract: Disclosed herein is a novel bacteriophage which has specific bactericidal activity against one or more Salmonella bacteria selected from the group consisting of Salmonella Enteritidis, Salmonella Typhimurium, Salmonella Gallinarum, and Salmonella Pullorum without affecting beneficial bacteria, in addition to showing excellent tolerance to acid, heat and desiccation. The novel bacteriophage can be widely used as an active ingredient for therapeutic agents, animal feeds or drinking water, cleaners and sanitizers for preventing and treating the infectious diseases caused by Salmonella Enteritidis, Salmonella Typhimurium, Salmonella Gallinarum or Salmonella Pullorum including salmonellosis, Salmonella food poisoning, Fowl Typhoid, and Pullorum disease or for controlling the salmonella bacteria.Type: GrantFiled: September 3, 2010Date of Patent: October 23, 2012Assignee: CJ Cheijedang CorporationInventors: Soo An Shin, Min Tae Park, Hyang Choi, Young Wook Cho, In Hye Kang, Su Jin Choi
-
Patent number: 8288146Abstract: The present invention relates to a novel bacteriophage, more particularly, a bacteriophage that has a specific bactericidal activity against Salmonella typhimurium, Salmonella gallinarum, or Salmonella pullorum, a composition for the prevention or treatment of infectious diseases including salmonellosis and Salmonella food poisoning caused by Salmonella typhimurium, Fowl typhoid caused by Salmonella gallinarum, and Pullorum disease caused by Salmonella pullorum, which comprises the bacteriophage as an active ingredient, and an animal feed, drinking water, cleaner, and sanitizer which comprise the bacteriophage as an active ingredient.Type: GrantFiled: September 15, 2009Date of Patent: October 16, 2012Assignee: CJ Cheiljedang CorporationInventors: In Hye Kang, Min Tae Park, Young Wook Cho, Soo An Shin, Hyang Choi
-
Publication number: 20120156174Abstract: The present invention relates to a novel bacteriophage, more particularly, a bacteriophage that has a specific bactericidal activity against Salmonella enteritidis, Salmonella typhimurium, Salmonella gallinarum and Salmonella pullorum, a composition for the prevention or treatment of infectious diseases including salmonellosis and Salmonella food poisoning caused by Salmonella enteritidis or Salmonella typhimurium, Fowl typhoid caused by Salmonella gallinarum, and Pullorum disease caused by Salmonella pullorum, which comprises the bacteriophage as an active ingredient, and an animal feed, drinking water, cleaner, and sanitizer which comprise the bacteriophage as an active ingredient.Type: ApplicationFiled: December 20, 2011Publication date: June 21, 2012Applicant: CJ CHEILJEDANG CORPORATIONInventors: Si Yong YANG, Soo An SHIN, Min Tae PARK, Young Wook CHO, In Hye KANG, Eun Mi SHIN
-
Patent number: 8148131Abstract: The present invention relates to a novel bacteriophage, more particularly, a bacteriophage that has a specific bactericidal activity against Fowl Typhoid causing Salmonella Gallinarum (SG) and Pullorum disease-causing Salmonella Pullorum (SP). Further, the present invention relates to a composition for the prevention or treatment of infectious diseases caused by Salmonella Gallinarum or Salmonella Pullorum, comprising the bacteriophage as an active ingredient. Furthermore, the present invention relates to feed and drinking water for poultry, sanitizers and cleaners, comprising the bacteriophage as an active ingredient.Type: GrantFiled: August 28, 2009Date of Patent: April 3, 2012Assignee: CJ Cheiljedang CorporationInventors: In Hye Kang, Min Tae Park, Young Wook Cho, Hyang Choi, Soo An Shin
-
Publication number: 20110052544Abstract: Disclosed herein are is a novel bacteriophage which has specific bactericidal activity against one or more Salmonella bacteria selected from the group consisting of Salmonella Enteritidis, Salmonella Typhimurium, Salmonella Gallinarum, and Salmonella Pullorum without affecting beneficial bacteria. Disclosed are also compositions, animal feeds or drinking water, cleaners and sanitizers for preventing and treating the infectious diseases caused by Salmonella Enteritidis, Salmonella Typhimurium, Salmonella Gallinarum or Salmonella Pullorum including salmonellosis, Salmonella food poisoning, Fowl Typhoid, and Pullorum disease or for controlling the salmonella bacteria.Type: ApplicationFiled: September 3, 2010Publication date: March 3, 2011Applicant: CJ CHEILJEDANG CORPORATIONInventors: Soo An Shin, Min Tae Park, Hyang Choi, Young Wook Cho, In Hye Kang, Su Jin Choi
-
Publication number: 20110052543Abstract: Disclosed herein are is a novel bacteriophage which has specific bactericidal activity against one or more Salmonella bacteria selected from the group consisting of Salmonella Enteritidis, Salmonella Typhimurium, Salmonella Gallinarum, and Salmonella Pullorum without affecting beneficial bacteria. Disclosed are also compositions, animal feeds or drinking water, cleaners and sanitizers for preventing and treating the infectious diseases caused by Salmonella Enteritidis, Salmonella Typhimurium, Salmonella Gallinarum or Salmonella Pullorum including salmonellosis, Salmonella food poisoning, Fowl Typhoid, and Pullorum disease or for controlling the salmonella bacteria.Type: ApplicationFiled: September 3, 2010Publication date: March 3, 2011Applicant: CJ CHEILJEDANG CORPORATIONInventors: Soo An Shin, Min Tae Park, Hyang Choi, Young Wook Cho, In Hye Kang, Su Jin Choi
-
Publication number: 20110052541Abstract: Disclosed herein are is a novel bacteriophage which has specific bactericidal activity against one or more Salmonella bacteria selected from the group consisting of Salmonella Enteritidis, Salmonella Typhimurium, Salmonella Gallinarum, and Salmonella Pullorum without affecting beneficial bacteria. Disclosed are also compositions, animal feeds or drinking water, cleaners and sanitizers for preventing and treating the infectious diseases caused by Salmonella Enteritidis, Salmonella Typhimurium, Salmonella Gallinarum or Salmonella Pullorum including salmonellosis, Salmonella food poisoning, Fowl Typhoid, and Pullorum disease or for controlling the salmonella bacteria.Type: ApplicationFiled: September 3, 2010Publication date: March 3, 2011Applicant: CJ CHEILJEDANG CORPORATIONInventors: Soo An Shin, Min Tae Park, Hyang Choi, Young Wook Cho, In Hye Kang, Su Jin Choi
-
Publication number: 20110052542Abstract: Disclosed herein is a novel bacteriophage which has specific bactericidal activity against one or more Salmonella bacteria selected from the group consisting of Salmonella Enteritidis, Salmonella Typhimurium, Salmonella Gallinarum, and Salmonella Pullorum without affecting beneficial bacteria, in addition to showing excellent tolerance to acid, heat and desiccation. The novel bacteriophage can be widely used as an active ingredient for therapeutic agents, animal feeds or drinking water, cleaners and sanitizers for preventing and treating the infectious diseases caused by Salmonella Enteritidis, Salmonella Typhimurium, Salmonella Gallinarum or Salmonella Pullorum including salmonellosis, Salmonella food poisoning, Fowl Typhoid, and Pullorum disease or for controlling the salmonella bacteria.Type: ApplicationFiled: September 3, 2010Publication date: March 3, 2011Applicant: CJ CHEILJEDANG CORPORATIONInventors: Soo An Shin, Min Tae Park, Hyang Choi, Young Wook Cho, In Hye Kang, Su Jin Choi
-
Publication number: 20100166709Abstract: The present invention relates to a novel bacteriophage, more particularly, a bacteriophage that has a specific bactericidal activity against one or more Salmonella bacteria selected from the group consisting of Salmonella Enteritidis, Salmonella Typhimurium, Salmonella Gallinarum, and Salmonella Pullorum. Further, the present invention relates to a composition for the prevention or treatment of infectious diseases including salmonellosis and Salmonella food poisoning caused by Salmonella Enteritidis or Salmonella Typhimurium, Fowl Typhoid caused by Salmonella Gallinarum, and Pullorum disease caused by Salmonella Pullorum, comprising the bacteriophage as an active ingredient. Furthermore, the present invention relates to a feed additive, drinking water, a cleaner and a sanitizer, comprising the bacteriophage as an active ingredient.Type: ApplicationFiled: December 22, 2009Publication date: July 1, 2010Applicant: CJ Cheiljedang CorporationInventors: In Hye Kang, Min Tae Park, Young Wook Cho, Soo An Shin, Hyang Choi
-
Publication number: 20100158870Abstract: The present invention relates to a novel bacteriophage, more particularly, a bacteriophage that has a specific bactericidal activity against Salmonella typhimurium, Salmonella gallinarum, or Salmonella pullorum, a composition for the prevention or treatment of infectious diseases including salmonellosis and Salmonella food poisoning caused by Salmonella typhimurium, Fowl typhoid caused by Salmonella gallinarum, and Pullorum disease caused by Salmonella pullorum, which comprises the bacteriophage as an active ingredient, and an animal feed, drinking water, cleaner, and sanitizer which comprise the bacteriophage as an active ingredient.Type: ApplicationFiled: September 15, 2009Publication date: June 24, 2010Applicant: CJ CHEILJEDANG CORPORATIONInventors: In Hye Kang, Min Tae Park, Young Wook Cho, Soo An Shin, Hyang Choi
-
Publication number: 20100135962Abstract: The present invention relates to a novel bacteriophage, more particularly, a bacteriophage that has a specific bactericidal activity against Fowl Typhoid causing Salmonella Gallinarum (SG) and Pullorum disease-causing Salmonella Pullorum (SP). Further, the present invention relates to a composition for the prevention or treatment of infectious diseases caused by Salmonella Gallinarum or Salmonella Pullorum, comprising the bacteriophage as an active ingredient. Furthermore, the present invention relates to feed and drinking water for poultry, sanitizers and cleaners, comprising the bacteriophage as an active ingredient.Type: ApplicationFiled: August 28, 2009Publication date: June 3, 2010Applicant: CJ CHEILJEDANG CORPORATIONInventors: In Hye KANG, Min Tae Park, Young Wook Cho, Hyang Choi, Soo An Shin
-
Publication number: 20090143408Abstract: Methods of inhibiting cytochrome P450 2D6 enzymes are provided that can be used for improving the treatment of diseases by preventing degradation of drugs or other molecules by cytochrome P450 2D6. Pharmaceutical compositions are provided that can act as boosters to improve the pharmacokinetics, enhance the bioavailability, and enhance the therapeutic effect of drugs that undergo in vivo degradation by cytochrome P450 2D6 enzymes.Type: ApplicationFiled: November 26, 2008Publication date: June 4, 2009Applicant: Sequoia Pharmaceuticals, Inc.Inventors: Michael EISSENSTAT, Dehui Duan, Ji-Hye Kang
-
Publication number: 20060276267Abstract: Disclosed is a dimple pattern on a golf ball, which consists of a plurality of dimples of various sizes for providing an optimum impact at the moment of hitting the golf ball. The dimple pattern formed on a circumferential surface of a golf ball has a total of 1070 dimples, including first dimples with a diameter of 3.8 mm, second dimples with a diameter of 3.2 mm, third dimples with a diameter of 2.4 mm, and fourth dimples with a diameter of 0.9 mm, wherein the number of the first dimples is 414, and the total number of the second to fourth dimples is 656. As the dimples of various sizes are repeatedly arranged with predetermined spaces, impact pressure is uniformly transferred to the golf ball over an entire contact area with a club face at the moment a golf club impacts on the golf ball, thereby removing the hook and slice, so that the straightness and stability of the golf ball while the golf ball is flying can be improved and the flight distance of the golf ball can be increased.Type: ApplicationFiled: May 23, 2006Publication date: December 7, 2006Inventor: Hye Kang
-
Publication number: 20060191003Abstract: Disclosed herein is a method of improving a security performance in a stateful inspection of TCP connections. In the security performance improvement method, a stateful inspection computer, placed between first and second hosts in which TCP connections are set up, creates a single session entry corresponding to a new SYN packet whenever the new SYN packet is generated between the first and second hosts. A state of connection progress is updated whenever a packet for a flow between the first and second hosts arrives at the stateful inspection computer. It is determined whether a time required for the updated connection progress has exceeded a predetermined timeout. Further, a session entry in an embryonic connection stage exceeding the timeout is purged.Type: ApplicationFiled: May 16, 2005Publication date: August 24, 2006Inventors: Sae-Woong Bahk, Hyo-Gon Kim, In-Hye Kang